In previous studies, the major factors predicting malignant lesions in BD-IPMN patients were solid components or mural nodules, main-duct dilatation, cyst size, thickened/enhancing cyst walls, serum CEA, serum CA 19-9, and new-onset DM [13,20]. The gene discussed is CEACAM5; the disease is cyst.